Semanat Injectioncontains semaglutide, a medicine belonging to the GLP-1 receptor agonist class. It is administered as a subcutaneous injection and is used for certain patients with type 2 diabetes and for weight management, depending on the prescribed formulation and medical guidance.

How Semanat Injection Works

Semaglutide weight loss injection acts on GLP-1 receptors involved in blood glucose regulation and appetite. It can support insulin release when blood glucose is elevated, reduce glucagon secretion, and slow gastric emptying. These effects are part of how semaglutide is used in appropriate patients.

Administration and Storage

Semanat is generally administered once weekly under the skin, with injection sites such as the abdomen, thigh, or upper arm. The dose and treatment schedule should be followed as prescribed and should not be changed without medical advice.

The product information lists storage at 2°C to 8°C and states that the medicine should not be frozen. Always check the instructions supplied with the specific product for handling and storage.

Possible Side Effects

Some commonly reported effects may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal discomfort
  • Headache
  • Indigestion

Side effects can vary between individuals. People using semaglutide should discuss their medical history and current medicines with a healthcare professional. Particular care may be needed when semaglutide is used with medicines such as insulin or sulfonylureas.

Key Product Details

  • Product Name: Semanat Injection
  • Active Ingredient: Semaglutide
  • Drug Class: GLP-1 receptor agonist
  • Dosage Form: Injection
  • Administration: Subcutaneous
  • Listed Strengths: 2 mg and 4 mg
  • Frequency: Once weekly
  • Storage: 2°C–8°C; do not freeze
  • Uses: Type 2 diabetes and weight management, as applicable to the prescribed formulation
  • Route of Administration: Under the skin

The appropriate dose and treatment plan depend on the individual and the specific product prescribed. Medical advice should be followed before starting, stopping, or changing treatment.

Semanat Injection: Key Product Details

 

Product detailInformationBrand nameSemanatActive ingredientSemaglutideDrug classGLP-1 receptor agonistDosage formSubcutaneous injectionListed strengths2 mg and 4 mgFrequencyOnce weeklyPrimary indications listedType 2 diabetes / weight managementStorageRefrigerate at 2°C–8°C; do not freezeManufacturer listedNatco Pharma, India

 

These details are based on the product information currently displayed on the Semanat page.

Final Note

Semanat Injection is a prescription medicine containing semaglutide and should be used according to the instructions provided for the specific product and strength. The appropriate dose and treatment plan can vary between individuals. Anyone starting semaglutide should discuss their medical history, other medicines, and any relevant health conditions with a qualified healthcare professional.

Product information: Semanat Injection (Semaglutide) – Online Generic Medicine

This article is for general educational information and should not replace advice from a qualified healthcare professional.

 

 

Contact Details

Website Name: Online Generic Medicine
Website: https://www.onlinegenericmedicine.com/
Email: [email protected]
Phone: +1 9177810616

For additional product information, refer to the product page and the instructions provided with the medicine. Semanat Injection should be used according to professional medical advice and the specific product information.